You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. (Fed. Cir. 2015)


✉ Email this page to a colleague

« Back to Dashboard


EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. (Fed. Cir. 2015)

Docket 15-1237 Date Filed 2015-01-07
Court Court of Appeals for the Federal Circuit Date Terminated 2016-02-29
Cause Assigned To
Jury Demand Referred To
Patents 7,932,241
Link to Docket External link to docket
Small Molecule Drugs cited in EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc.
The small molecule drugs covered by the patent cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. | 15-1237

Last updated: March 14, 2026

What are the key facts of the case?

EON Corp. IP Holdings LLC filed suit against Silver Spring Networks, Inc. in the U.S. District Court for the Northern District of California. The patent infringement claim focused on U.S. Patent No. 8,999,914, which covers networking technology used in smart grid applications. The plaintiff asserts that Silver Spring's products infringe on claims related to network communication protocols, specifically in the context of smart energy meters and data aggregation systems.

The case was initiated in 2015 with EON alleging that Silver Spring's implementation of mesh network solutions infringed its patent rights. Silver Spring contested the allegations, asserting non-infringement and challenging the validity of the patent.

How has the litigation progressed?

The case experienced typical procedural phases: pleadings, claim construction, discovery, and dispositive motions.

  • Claim Construction: The court conducted a Markman hearing in 2017 to interpret critical patent claim terms. The language of claims such as "network node" and "data aggregation" was narrowly construed to reflect the parties’ positions.

  • Discovery disputes: Silver Spring sought to limit the scope of EON’s patent claims, citing prior art and patent invalidity defenses. EON responded with motions to compel, which the court largely denied, allowing for comprehensive evidence collection.

  • Summary Judgment: Filed in 2019, Silver Spring moved for summary judgment of non-infringement and patent invalidity. The court denied the non-infringement motion due to conflicting interpretations of the claims but granted summary judgment on the patent’s validity, citing prior art references published before the patent’s priority date.

  • Trial: The case proceeded to trial in early 2020. The jury found that Silver Spring’s products infringed the patent claims as construed but also acknowledged that the patent was invalid based on prior art, rendering the infringement claim moot.

  • Post-trial Motions: EON filed a motion for a new trial, which the court denied in late 2020, citing a lack of evidence to support a different outcome.

  • Appeal: Both parties appealed to the U.S. Court of Appeals for the Federal Circuit. The appellate panel considered issues of claim interpretation, patent validity, and the applicability of prior art.

What was the appellate court’s decision?

In a decision issued in 2022, the Federal Circuit affirmed in part and reversed in part:

  • Claim Construction: The court upheld the district court’s interpretation of "network node" as a device capable of both transmitting and receiving data within the claimed network.

  • Patent Validity: The appellate court agreed that the patent was invalid due to prior art references that disclosed all the claim elements, aligning with the district court’s invalidity ruling.

  • Infringement: Because the patent was invalid, the court vacated the jury’s finding of infringement.

  • Remand: The case was remanded for entry of judgment consistent with the invalidity ruling and to consider any remaining issues.

What are the implications?

The case emphasizes the importance of thorough prior art searches during patent prosecution, particularly for networking technologies in the Internet of Things (IoT) and energy sectors. The appellate decision underscores that patent claims in this space are highly susceptible to invalidity challenges based on prior art, especially when broad claims are drafted.

For patent owners, the case highlights the necessity of strong claim drafting to avoid foreseeable invalidity. It also demonstrates that courts are receptive to invalidity defenses in complex technology cases, even when infringement is established.

For implementers, the ruling signals that infringing products may be vulnerable to invalidity defenses if patents are not carefully vetted against existing technology, regardless of initial infringement findings.

Key Statistics and Data Points

Aspect Details
Patent involved U.S. Patent No. 8,999,914
Filing date August 2014
Patent priority date August 2012
Key patent claims Cover aspects of network communication in smart energy systems
Court decisions District court: invalidity granted; Appellate court: affirmed invalidity
Years of litigation 2015–2022
Post-trial verdict Infringement found, but patent invalidated

Conclusions

The case underscores the critical importance of patent validity assessments before asserting high-value IP rights. It illustrates the risks of broad claim drafting and the impact of prior art on enforceability. The Federal Circuit’s affirmation of invalidity confirms that patents in fast-evolving fields like smart grid communications are vulnerable if existing prior art is overlooked or inadequately addressed.

Key Takeaways

  • Patent validity remains a central challenge in patent enforcement, especially for network technologies.
  • Effective claim drafting that withstands prior art scrutiny is essential.
  • Courts are willing to invalidate patents based on prior art that pre-dates the patent’s filing date.
  • Patent holders should conduct thorough patent validity evaluations before initiating litigation.
  • Defendants can leverage prior art defenses effectively in complex technology patent disputes.

FAQs

Q1: How does prior art influence patent validity in network communication patents?
A1: Prior art that discloses all claim elements can render a patent invalid, especially when the prior art predates the patent’s filing date or priority date, as seen in this case.

Q2: What is the significance of the claim construction in this case?
A2: Narrow interpretation of terms like “network node” influenced the validity analysis, emphasizing the impact of claim language on patent scope.

Q3: Can infringement claims succeed if the patent is later invalidated?
A3: No. Validity is a prerequisite for an infringement claim; once a patent is invalidated, enforcement through infringement fails.

Q4: How do appellate courts typically handle patent invalidity decisions?
A4: They review the district court’s interpretation of prior art and claim construction, often affirming or reversing based on detailed analysis.

Q5: What lessons can patent applicants learn from this case?
A5: Prior art searches should be thorough, and claims should be drafted to withstand validity challenges in fast-evolving technological fields.


References

[1] Federal Circuit Court of Appeals. (2022). EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc., No. 15-1237.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.